Characteristics of Migraine Patients Who Successfully Discontinued Anti-CGRP Monoclonal Antibodies: A Single-Center Retrospective Study

Aimovig (erenumab-aooe) - Amgen

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

Ajovy (fremanezumab-vfrm) - Teva

https://onlinelibrary.wiley.com/doi/10.1111/ene.70629

N. Imai 1; R. Narita 1; A. Moriya 1; R. Suzuki 1; E. Kitamura 2

Jun 12, 2026